The beginning: 1920 -1940

The story of Angelini started in 1919 in Ancona, in a small laboratory where Francesco Angelini began his ascent in the industrial world. In 1940 he founded ACRAF, which stands for Aziende Chimiche Riunite Angelini Francesco, whose main activities are still the production and distribution of drugs.

Immediately after the war, Francesco Angelini imports the first vitamin B12 in Italy, a tonic for treating anemia, a widespread disease at that time.  The drug is produced and marketed under the trademark Dobetin and receives a very positive response from the market.  This operation represents Angelini’s first great success.


1950s: The turning point

Francesco Angelini consolidates assets and more markedly transforms his business into an industry.  In agreement with is son Igino,  at the beginning of the fifties he decides to expand operations to Rome, where the head office is now situated.  During the same period, Company activities are diversified and Angelini enters the field of consumer goods:   1958 sees the foundation of Fater,  a Pescara company active in the production of baby diapers and sanitary napkins.  In the same year, Tachipirina is launched on the market,  an anit-flu drug containing paracetamol which today  is the most widely prescribed drug by pediatricians and one of the top three best-selling drugs in Italy.


1960s and 1970s: "The golden age"

In 1963, in full baby boom, Fater is the first in Italy to launch Lines brand "disposable" diapers , and two years later, the first line of women's sanitary towels (always Lines brand).  The name Lines was chosen because it recalls linen, the material used to make these sanitary towels used up to that time.  In 1964, upon the death of Francesco Angelini, his son Igino takes over the management of the company.  In the 60s production begins for the first original molecules of Angelini pharmaceutical research.

Between the sixties and seventies, important and innovative molecules were discovered such as oxolamina (anti-cough), benzydamine (anti-inflammatory), trazodone (antidepressant) and dapiprazole (anti-glaucoma).  In the field of production technology, in 1975 Angelini introduces the first Italian machinery for manufacturing diapers and is among the first to use computers for design and to introduce electronics in production lines.


1980s: A modern and international company

In 1985, Angelini grasped the potential of ibuprofen in Italy and launched a self-medication analgesic drug specifically against headaches, Moment, the first example of marketing applied to pharmaceuticals. Moreover, Igino Angelini, ever since the Sixties has been convinced of the importance of communication for the success of his products.

In the 80s, the Angelini Group began its internationalization process with the creation of manufacturing and commercial facilities in Spain and Portugal.  Activities on the Iberian peninsula begin in 1979 with the acquisition of the Lepori group of Barcelona, consisting of three companies: Farma Lepori and L. Lepori, active in the production and marketing of drugs, and Laboratorios Ausonia, specializing in the production of talc and childcare articles.


1990s: Diversification and strategic alliances

In 1993, upon the death of Igino Angelini, his son Francesco takes the helm of the Group and further strengthens its position in the health and hygiene sector by strengthening the alliance established in 1992 with Procter & Gamble.  In Italy, the American multinational company, with the international brand Pampers (baby diapers) complements Lines for women's sanitary towels, while the Lines nappy brand is licensed to another industrial group for antitrust reasons.  In the mid-'90s, Francesco Angelini, in view of diversifying business activities,  enhances the food group, created in the late fifties.  In fact in 1993 he enters the market of quality wines, oils and cured meats.


From 2000 to today: Strengthening core business and internationalization

Since 2000, Angelini is one of the leading manufacturers and distributors of generic drugs in Italy.  In that same year, Amuchina, Genoa-based company that produces the eponymous disinfectants and sanitizers, a leader in this sector in Italy, joins the Angelini Group.

Between 2000 and 2001, it acquires Helsinn Produtos Farmacêuticos and Helfarma Produtos Farmacêuticos two Portuguese pharmaceutical companies, which become part of the company Angelini Farmacêutica, thereby consolidating Angelini’s presence in the Iberian peninsula.

In 2002, Angelini purchases Farmamed, a leading company in Italy for marketing para-pharmaceutical products sold in supermarkets and in 2003 makes its entrance on the market of herbal products and supplements with the acquisition of Body Spring.

In recent years, through trade agreements and partnerships, Angelini is laying the groundwork for development in other countries.  In 2004, in fact, the company acquired a significant stake in Elder Pharma, a leading pharmaceutical company on the Indian market.  In 2007 it acquired CSC Pharmaceuticals, pharmaceutical group active in Central and Eastern Europe and Angelini's strategic partner since 1998, while in 2008 it acquires the Greek pharmaceutical group Angelini Pharma Hellas.  Since 2009 Alcavis HDC LLC, a U.S. company that sells antiseptics and disinfectants, and the Pakistani pharmaceutical company Angelini Pharmaceuticals (PVT) LTD are part of the Group.

Between 2010 and 2011, the Angelini group also significantly strengthens its presence in the wine sector with the acquisition of the winery Puiatti in Friuli and the company Bertani, best known for the production of Amarone in the Verona area.

In 2011 the brand Infasil is acquired from P&G, Italian leader in deodorants and personal hygiene sector.

Always in 2011, Angelini moves its first steps in Turkey with the acquisition of the pharmaceutical company Angelini Ilac San. Ve Tic. 

In 2012, the Angelini group's product portfolio is enriched with the trademarks ACE and Neoblanc (market of products for household cleaning), acquired from Fater, while in the Perfumery sector the Group's commitment is strengthened through the acquisition of the company ITF, with offices in Italy and Germany.

Since 2014 Bertani Domains is the company in charge of the activities of the wine sector. 

In recent years Angelini has focused its efforts on strategic therapeutic areas: pain and inflammation, mental health, infectious diseases. Thanks to marketing agreements with major multinational pharmaceutical companies, Angelini has expanded its product portfolio with top brands, including international ones: in the area of pain and inflammation, Vellofent (fentanyl) and Tachifene (paracetamol and ibuoprofen); in the area of mental health Adasuve (loxapine), Resilient (lithium) and Latuda (lurasidone hydrochloride); in the area of infectious diseases Xydalba (dalbavancin).